Role of Artificial Intelligence in Enhancing Patient Engagement and Brand Loyalty in the Pharmaceutical Industry: A Review

The study explores how AI-driven tools like chatbots, virtual health assistants, machine learning algorithms, and personalised recommendation systems enable patients to make educated decisions and follow treatment plans. By changing how businesses engage with consumers, customise healthcare experiences, and fortify brand ties, artificial intelligence (AI) is drastically changing the pharmaceutical sector. The strategic role of AI in improving patient engagement and cultivating brand loyalty throughout the pharmaceutical value chain is examined in this article. It does this by drawing on recent advancements in digital health, predictive analytics, and customer relationship management. Pharmaceutical companies may provide more focused communication, enhance treatment results, and foster trust through data-driven personalisation by integrating AI technology. However, legislative impediments, ethical issues, and data privacy concerns continue to be major roadblocks to wider implementation. This study offers a conceptual framework that shows how AI skills lead to increased patient happiness and long-term brand loyalty by examining recent research and industry practices. According to the research, using AI strategically not only improves patient involvement but also acts as a crucial differentiator for competitive advantage in the rapidly changing pharmaceutical industry.